Skip to content

Clinical trials

Completed Respiratory Tract Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Status: Completed Country / region: China Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20111
20131
20141
20173
20181
20192
20202
20212
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CanSino Biologics Inc.2
Guangzhou JOYO Pharma Co., Ltd2
Alpha Biopharma (Jiangsu) Co., Ltd.1
AstraZeneca1
Chinese Society of Lung Cancer1
GlaxoSmithKline1
Guangzhou Institute of Respiratory Disease1
Hoffmann-La Roche1
InSilico Medicine Hong Kong Limited1
Jiangsu HengRui Medicine Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases19
Lung Diseases8
Lung Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Idiopathic Pulmonary Fibrosis3
Neoplasms3
Pulmonary Fibrosis3
Respiratory Tract Infections3
Thoracic Neoplasms3
Asthma2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.